Glowops
Glowops
Stealth ModeAI operations software for medical clinics, with human review, auditability, and adoption built in.
About
What does Glowops do?
GlowOps builds AI operations software to automate administrative tasks for medical clinics, addressing issues like unanswered calls, incomplete intake, and insurance claim denials. Their platform aims to reduce the administrative burden on clinic teams, allowing them to focus on patient care while maintaining human oversight and ensuring compliance within HIPAA-regulated environments. GlowOps serves private practices, specialty clinics, urgent care, and multi-location medical groups.
What industry does Glowops operate in?
Glowops operates in HealthTech, Vertical SaaS, AI Tool, Workflow Automation, Medical Clinics, AI Operations Software.
Building a mental health app focused on emotional well-being and self-care.
A free platform offering mental health tests and AI-powered self-help tools for anonymous mental well-being checks.
An AI copilot for doctors that provides immediate, evidence-based answers to clinical questions from peer-reviewed medical sources.
6dvc is developing usable, scalable, and accurate AI agents for healthcare, specifically focusing on cardiovascular care transformation.
Lymesignal is an AI-assisted platform that transforms publicly available Lyme disease discussions into organized, searchable community knowledge.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
A science-based digital program and app designed to help adults manage ADHD symptoms and build coping skills.
Aetios AI builds advanced clinical tools for mental health professionals, leveraging AI for psychological formulation and treatment planning.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 17 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.

